Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elemene Injectable Emulsion in Refractory Glioblastoma
NCT04674527Phase 2Unknown
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Jun 2021
- Primary completion
- Jun 2023
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Elemene in glioblastoma (GBM), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Status: unknown.
02
Drugs
Elemene
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT04674527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04674527.